CogState signs $400,000 functional food deal
Monday, 13 February, 2006
CogState (ASX:CGS) is to provide cognition testing services to a European food products company in a contract worth more than AUD$400,000.
Over the next 12 to 15 months, Cogstate will be studying the effect of the European company's dietary product on cognitive function in a trial conducted at the Murdoch Children's Research Institute, Melbourne.
If the trial demonstrates cognitive function enhancement as a result of people consuming its dietary supplement, the food products company will be able to make marketing claims in relation to the product.
Novel antibiotic activates 'suicide' mechanism in superbug
Researchers have discovered a new class of antibiotic that selectively targets Neisseria...
Modifications in the placenta linked to psychiatric disorders
Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...
ADHD may be linked with an increased risk of dementia
An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...